Craneware (CRWRF) Stock Price, News & Analysis

Company Overview

Craneware plc is a software company that specializes in healthcare revenue integrity and financial performance solutions. Its cloud-based platform enables hospitals and health systems to identify and recover lost revenue, optimize charge capture, and ensure compliance with payer contracts. The company’s technology combines clinical, financial and operational data to deliver analytics, auditing and payment integrity tools designed to reduce revenue leakage and improve margins.

Founded in 2001 and headquartered in Edinburgh, Scotland, Craneware has developed a suite of products that support every stage of the hospital revenue cycle. Key offerings include solutions for contract management, charge assurance, retrospective review and benchmarking, all of which integrate seamlessly with leading electronic health record and billing systems. The company continually invests in research and development to expand its predictive analytics and machine learning capabilities.

Under the leadership of Chief Executive Officer David Soucy, Craneware has grown from a single-product provider into a global SaaS business. The executive team emphasizes a client-first approach, working closely with customers to tailor implementations, provide training and deliver ongoing managed services. Governance is overseen by a board of directors with extensive experience in both healthcare and technology sectors.

Craneware serves more than 450 hospitals and health systems across North America, the United Kingdom, Canada and Australia. With offices in Edinburgh and multiple U.S. locations, the company supports both large multi-hospital networks and individual facilities. Its global footprint and industry partnerships allow Craneware to address the evolving regulatory landscape and help providers navigate complex reimbursement environments.

Key Stats

• Today's Range: $24.00 to $24.20
• 50-Day Range: $24.20 to $24.20
• 52-Week Range: $24.20 to $34.00
• Volume: N/A
• Average Volume: 725 shs
• Market Capitalization: N/A
• P/E Ratio: 76.34
• Dividend Yield: 0.82%
• Price Target: N/A
• Consensus Rating: N/A

Craneware Stock Analysis - MarketRank™

Craneware scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Craneware.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Craneware is 76.34, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 40.28.

Price to Earnings Ratio vs. Sector

The P/E ratio of Craneware is 76.34, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.22.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Craneware has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Craneware has recently increased by 21.12%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Craneware pays a meaningful dividend of 2.44%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Craneware does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Craneware is 62.40%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Sentiment

Craneware has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.

Company Ownership

• Score: 0.6 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Craneware insiders have not sold or bought any company stock.

Percentage Held by Institutions

48.19% of the stock of Craneware is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Today: 7/07/2026
• Next Earnings (Estimated): 9/22/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CRWRF
• CIK: N/A
• Web: www.thecranewaregroup.com
• Phone: 441315503100
• Fax: N/A
• Employees: 734
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 76.34
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A